Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026)
Travere Therapeutics (TVTX) recorded Selling, General & Administrative of $96.11 million in Q2 2026, up 53.6% from $62.58 million a year earlier and up 19.8% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026) Analysis & Trends
On a TTM basis, Travere Therapeutics' Selling, General & Administrative came in at $364.51 million as of Jun 30, 2026, up 41.2% year-over-year; for FY2025, it came in at $337.2 million, up 27.7% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 19.9% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $264.12 million in FY2024 (-0.5%), $265.54 million in FY2023 (+34.4%), $197.52 million in FY2022 (+56.4%) and $126.28 million in FY2021 (-7.0%).
- Quarterly Selling, General & Administrative has ranged from $18.48 million in Q4 2021 to $101.69 million in Q4 2025 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 20.2% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 209.0% in Q4 2022, against a decline of 48.3% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $80.25 million (Q1 2026), $101.69 million (Q4 2025) and $86.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Travere Therapeutics | 5.36 Bn | 4.96 Bn | 167.41 Mn | 96.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.11 Mn |
| Mar 31, 2026 | 80.25 Mn |
| Dec 31, 2025 | 101.69 Mn |
| Sep 30, 2025 | 86.45 Mn |
| Jun 30, 2025 | 62.58 Mn |
| Mar 31, 2025 | 60.41 Mn |
| Dec 31, 2024 | 69.50 Mn |
| Sep 30, 2024 | 65.62 Mn |
| Jun 30, 2024 | 64.78 Mn |
| Mar 31, 2024 | 64.22 Mn |
| Dec 31, 2023 | 63.59 Mn |
| Sep 30, 2023 | 67.80 Mn |
| Jun 30, 2023 | 68.20 Mn |
| Mar 31, 2023 | 65.95 Mn |
| Dec 31, 2022 | 57.09 Mn |
| Sep 30, 2022 | 52.42 Mn |
| Jun 30, 2022 | 52.98 Mn |
| Mar 31, 2022 | 46.79 Mn |
| Dec 31, 2021 | 18.48 Mn |
| Sep 30, 2021 | 36.07 Mn |
API Access
Travere Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();